India Medical Diagnostics & Research Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus News Medical Diagnostics & Research
Vimta Labs Ltd (BOM:524394) Q2 2025 Earnings Call Highlights: Strong Financial Performance and Strategic Focus
Vimta Labs Ltd (BOM:524394) reports robust growth with a 26.4% revenue increase and over 100% rise in profit after tax, while navigating industry challenges and strategic divestments. Nov 09, 2024
GuruFocus News Medical Diagnostics & Research
Syngene International Ltd (BOM:539268) Q2 2025 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities
Despite a year-on-year revenue dip, Syngene International Ltd (BOM:539268) shows promising sequential growth and strategic advancements in biologics and supply chain resilience. Oct 25, 2024
GuruFocus News Medical Diagnostics & Research
Thyrocare Technologies Ltd (BOM:539871) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Expansion
Thyrocare Technologies Ltd (BOM:539871) reports a record high revenue of INR 177.4 crore, driven by strong growth in pathology and strategic acquisitions. Oct 24, 2024
GuruFocus News Medical Diagnostics & Research
Dr. Lal PathLabs Ltd (BOM:539524) Q2 2025 Earnings Call Highlights: Strong Revenue and Profit Growth Amidst Strategic Expansion
Dr. Lal PathLabs Ltd (BOM:539524) reports robust financial performance with significant growth in revenue and profit, while focusing on expanding its service network and investing in technology. Oct 24, 2024
GuruFocus Research Medical Diagnostics & Research
Metropolis Healthcare Ltd (BOM:542650) Q4 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Expansion
Metropolis Healthcare Ltd (BOM:542650) reports robust financial performance and outlines future growth strategies. Sep 13, 2024
GuruFocus Research Medical Diagnostics & Research
Vimta Labs Ltd (BOM:524394) Q4 2024 Earnings Call Transcript Highlights: Strong EBITDA Margin Improvement Amidst Flat Revenue Growth
Vimta Labs Ltd (BOM:524394) reports significant EBITDA margin gains and maintains a net debt-free balance sheet despite revenue challenges. Sep 13, 2024
GuruFocus Research Medical Diagnostics & Research
Metropolis Healthcare Ltd (BOM:542650) Q1 2025 Earnings Call Transcript Highlights: Strong Financial Performance and Strategic Expansion
Metropolis Healthcare Ltd (BOM:542650) reports robust revenue and profit growth, driven by increased patient volumes and strategic market expansion. Aug 13, 2024
GuruFocus Research Medical Diagnostics & Research
Thyrocare Technologies Ltd (BOM:539871) Q1 2025 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Expansions
Thyrocare Technologies Ltd (BOM:539871) reports a robust 16% year-on-year revenue growth, driven by pathology and partnership businesses. Jul 26, 2024